Post-transplantation lymphoproliferative disease in heart and heart–lung transplant recipients: 30-year experience at Stanford University
- 1 May 2003
- journal article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 22 (5) , 505-514
- https://doi.org/10.1016/s1053-2498(02)01229-9
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- EPSTEIN-BARR VIRUS-INDUCED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERSTransplantation, 1999
- Pre-Transplant Immunological Profile and Risk Factor Analysis of Post-Transplant Lymphoproliferative Disease Development: The Results of a Nested Matched Case-Control StudyLeukemia & Lymphoma, 1999
- Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD)Springer Seminars in Immunopathology, 1998
- Development of monoclonal gammopathy precedes the development of Epstein-Barr virus-induced posttransplant lymphoproliferative disorderLiver Transplantation and Surgery, 1996
- POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERInfectious Disease Clinics of North America, 1995
- Pretransplantation Assessment of the Risk of Lymphoproliferative DisorderClinical Infectious Diseases, 1995
- A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart TransplantationNew England Journal of Medicine, 1992
- Increased Incidence of Lymphoproliferative Disorder after Immunosuppression with the Monoclonal Antibody OKT3 in Cardiac-Transplant RecipientsNew England Journal of Medicine, 1990
- Cancers Complicating Organ TransplantationNew England Journal of Medicine, 1990
- Posttransplant lymphoproliferative disorders in heart-lung transplant recipients: Primary presentation in the allograftHuman Pathology, 1989